43 results
Page 2 of 3
6-K
EX-99.1
2b5in51mxn1xu x5
30 Mar 22
Sol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments
7:53am
6-K
EX-99.1
pxum7dxyix6o 0a1
5 Jan 22
Current report (foreign)
9:03am
6-K
EX-99.1
87m9 4xgagwrur446q
16 Nov 21
Current report (foreign)
4:05pm
6-K
EX-99.1
vxqw u67yatoualiz
12 Nov 21
Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments
12:00am
6-K
EX-99.1
l08u0cehuqkrmk068
8 Nov 21
Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner
4:55pm
6-K
EX-99.1
ix9t9q753 b47jpki8no
9 Sep 21
Current report (foreign)
11:29am
6-K
EX-99.1
icdz3b6ayrns vr
4 Aug 21
Current report (foreign)
7:17am
6-K
EX-99.1
igmy nxujxrzjsvciyh
4 Aug 21
Sol-Gel Technologies Reports Second Quarter 2021 Financial Results and Highlights
7:16am
6-K
EX-99.1
crl5kv n0
27 Jul 21
TWYNEO®, a once-daily cream treatment for acne vulgaris, is the first FDA‑approved fixed‑dose combination of tretinoin and benzoyl peroxide
10:39am
6-K
EX-99.1
ly7vzr
28 Jun 21
Current report (foreign)
8:16am
6-K
EX-99.2
n0bw5dr
28 Jun 21
Sol-Gel Technologies and Galderma announce exclusive licenses for the About Papulopustular Rosacea
8:14am
6-K
EX-99.1
c0fq p94mlw
28 Jun 21
Sol-Gel Technologies and Galderma announce exclusive licenses for the About Papulopustular Rosacea
8:14am
6-K
EX-99.1
7nivu
13 Feb 20
Sol-Gel Announces Positive Topline Results from Open-Label, Long-Term Safety
4:25pm
6-K
EX-99.1
ehhbymw
15 Nov 19
Sol-Gel Technologies Reports Third Quarter 2019 Financial Results and Corporate Update
9:02am
6-K
EX-99.2
yfitwmxfr46kgeu2sih
25 Jul 19
Current report (foreign)
6:02am
6-K
EX-99.1
n8014b6q3tde1n45i2
23 Jul 19
Current report (foreign)
8:19am
6-K
EX-99.1
siifgc x6jjbr
8 Jul 19
Current report (foreign)
8:58am